欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0421/001
药品名称Cardisure Oral Solution 3.5 mg/mL
活性成分
    • pimobendan 3.5 mg/ml
剂型Oral solution
上市许可持有人Dechra Regulatory B.V., Handelsweg 25 5531 AE Bladel Netherlands
参考成员国 - 产品名称Ireland (IE)
Cardisure 3.5 mg/ml Oral Solution
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Cardisure 3,5 mg/ml
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Cardisure 3,5 mg/ml Lösung zum Eingeben für Hunde
    • Portugal (PT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Cardisure vet.
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Cardimed 3,5 mg/ml šķīdums iekšķīgai lietošanai suņiem
    • Lithuania (LT)
    • Estonia (EE)
      Pimocard
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2019/07/04
最近更新日期2023/02/28
药物ATC编码
    • QC01CE90 pimobendan
申请类型
  • TypeLevel1：non-food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase